Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Zwecken und zum Privatgebrauch gespeichert und kopiert werden.
Introduction
Patent applications are a leading indicator of emerging technological prowess and indicate a global shift from the West to the East in recent years. Stimulated by national policy, e.g. patent subsidies, in 2011 China surpassed the USA as the greatest global source of patent applications (OECD 2014) . Since 2013, China has ranked third in terms of applications made under the Patent Cooperation Treaty (PCT), typically preceding the international commercialization of valuable inventions (WIPO 2014a, Grupp and Schmoch 1999) .
However, without comparable information on patent quality it remains questionable whether China's rapid expansion in PCT applications constitutes the rise of a new technological superpower. Although there is a consensus in the literature that frequent citations by subsequent patents indicate higher quality (Jaffe and Rassenfosse 2016 , Harhoff et al. 1999 , Trajtenberg 1990 ) and provide the best approximation of patent quality (Gambardella et al. 2008 , Reitzig 2004 , currently available quality measures do not provide unbiased country comparisons.
In this paper we develop a quality measure based on citations from international search reports (ISRs), generated during the international phase of PCT applications. Under the PCT system, applicants can simultaneously seek protection in up to 148 countries (WIPO 2014a).
Our main index, which only considers citations of foreign PCT applications, not only allows for cross-country comparisons of patent quality but is also unaffected by national policies.
Covering the start of China's patent expansion, we apply our indices to the population of PCT applications filed between 2001 and 2009. For external validation of our measure, we calculate the indices for patent portfolios of all domestic firms listed in mainland China and regress those indices on relevant firm characteristics, such as R&D.
We find that China's PCT expansion has taken place to the detriment of patent quality.
According to our main index, China's average patent quality only reaches 32.1% of non-Chinese applicant countries and declines from 44.9% to 30.4% between 2001 and 2009 . In global comparison, the USA leads with an average value of 123.3%, followed by Korea (93.5%), Germany (71.9%), and Japan (59.6%). We measure national technological capacity by quality-adjusted patent counts, i.e. by multiplying PCT counts with our index, and confirm the leading position of the USA. Without quality adjustment, China's national technological capacity takes the third position, thereby overtaking Germany and Korea. If quality adjustment is applied, China remains in the fifth position and a widening gap between China and the leading USA is revealed. Regression results confirm that foreign PCT applications more often cite patents from Chinese firms with more extensive R&D but question the reliability of citations from Chinese PCT applications as quality measure.
The contributions of this paper are twofold. First, we develop a measure of patent quality that allows for cross-country comparisons. Our indices have a wide applicability.
Beyond the application in this study, they may be used to measure the quality of national patents for any country included in the minimum documentation required for prior art search during the international phase. Second, we provide novel evidence on the quality of China's patents and technological capacity. While the policy-driven expansion of Chinese patent applications has occurred at the cost of quality, its technological capacity has increased less than would be expected if one considers only the number of patents applied for. Our results reveal that the number of Chinese patent applications and citations thereof are questionable measures of innovation levels and quality, respectively, and emphasize that measures stop serving as reliable measures if they become the target of policy (Goodhart 1975 , Lucas 1976 .
Prior literature has investigated the quality of Chinese patents on the basis of citationbased measures. Kwon et al. (2014) analyze patents granted at the US Patent and Trademark Office (USPTO) and find that patents with Chinese inventors closed the citation gap to patents with US-American inventors between 2000 and 2009. However, the comparability of patents from China and the US is limited because firms tend to select only their more valuable inventions for protection abroad. Therefore Chinese patents are a positively selected sample. Branstetter et al. (2015) take a different angle by investigating the role of inventors and patent owners. Of patents granted at the USPTO with involvement from either Chinese inventors or firms, the ones with non-Chinese co-inventors or multinational firms as patent owners receive more citations compared to the fully Chinese patents.
The remainder of the paper is organized as follows. In section 2, we develop our measure of patent quality that allows for unbiased cross-country comparison. In section 3 we apply the indices to the data and show results for patent quality, national technological capacities, and the external validation of our indices. Finally, section 4 offers a brief discussion of policy implications.
Measurement of patent quality
A challenge in assessing patents or in measuring national technological capacity using patent applications is that patents vary in their commercial value and technological impact.
Evidence suggests that most patents are almost worthless, whereas only a few represent technological breakthroughs of high value (Gambardella et al. 2008) . If explicit value information is not available, measures based on citations provide the best approximation of patent quality (Gambardella et al. 2008 , Reitzig 2004 . Frequent citations by subsequent patents indicate higher quality, given that differences affecting citation propensity, e.g. technology, are controlled for (Jaffe and Rassenfosse 2016 , Harhoff et al. 1999 , Trajtenberg 1990 ). In cross-country studies, however, the comparability of citation counts has several limitations. First, as applicants only select more valuable patents for protection abroad (due to higher filing and translation costs), a direct comparison of domestic and foreign applications is hardly informative (Harhoff et al. 2003) . Second, heterogeneous examination practices lead to significant variation in citation counts generated across national patent offices (Michel and Bettels 2001) . Third, patent examiners are biased towards citing domestic patents from their home country (Michel and Bettels 2001, Bacchiocchi and Montobbio 2010) .
We ensure comparability by exclusively relying on citations generated by ISRs during the international phase of PCT applications. Under the PCT system, applicants can simultaneously seek protection in up to 148 countries, typically preceding the international commercialization of valuable inventions (Grupp and Schmoch 1999, WIPO 2014a) . A search for prior art occurs in the international phase within 30 months after filing the application.
National patent offices act as international search authorities (ISAs) where all examiners follow the same strict examination rules from the World Intellectual Property Organization (WIPO) when drafting an ISR (WIPO 2014b). More details on the PCT process can be found in the appendix.
Our quality measure allows for technology-specific cross-country comparisons. The ISR index γκ defines the quality level of PCT applications, where the home country of the first applicant c=γ and technology class k=κ. The index is calculated at the annual level but we omit time indices to simplify notation.
is the proportion of patent i within technology class κ. is the sum of over all patents of country γ, i.e. ∑ | ∈ . The comparison group is denoted by ̅ and contains all patents that do not belong to country γ. The indicator function equals one if application i is cited by application j within the defined time window and zero otherwise. j ranges from 1 to I, i.e. it covers the full population of PCT applications.
The country-level index is obtained by averaging ISR indices across technology classes:
1 * is the total number of patents of country γ. A value of the ISR index of larger (smaller)
than 100% signifies quality above (below) the comparison group.
From now on we drop the country subscript γ and instead use the subscript to indicate the following citation types: foreign citations F, domestic citations D, and self citations S. The indicator function of our main index F only considers non-self-citations received by foreign countries, i.e. from countries other than the applicant country. In addition to non-selfcitations from foreign countries considered in index F , the alternative index FD also accounts for non-self-citations of domestic origin, which measure the technological self-reliance of an economy. By also considering self-citations, index FDS acknowledges the extent to which an applicant builds on own prior art (Hall et al. 2005) . Note that only our main index F is invariant with respect to national policy as it relies only on citations generated outside of national boundaries.
Empirical analysis

Data
Covering PATSTAT and EEE-PPAT applicant name harmonization (Magerman et al. 2006 For details on the firm data see Boeing et al. (2016) .
Main quality index
Index F , with a mean value of 32.1%, shows that China's patent quality is significantly below that of the comparison group, which consists mainly of high-income countries ( The appendix provides details about the role of language in the search for prior art and in the calculation of the correction factor. , there is no English publication or equivalent document in English available for 56% of PCT applications of Chinese origin. Only these applications require an adjustment. We quantify the language bias by calculating the share of non-self-citations from outside of China in all non-self-citations made before and after a document in English is available. As this share increases by 38 percentage points, from 31% to 69%, we arrive at an adjustment factor of 1.38. We apply this factor in full for PCTs that do not obtain an English equivalent during the full 3-year citation window and weigh the factor for PCTs that obtain an English equivalent within three years. Taking the relative importance of the different cases into account, we arrive at a final correction factor of 1.11.
National technological capacity
We measure national technological capacity by quality-adjusted patent counts, i.e. by multiplying PCT counts with the year-and country-specific mean value of index F . Figure 1 shows the development of PCT applications with and without quality adjustment for the five largest applicant countries. Where exclusively patent counts are considered, the USA takes the leading position. This lead is increased when moving to the quality-adjusted PCT applications -highlighting the technological influence of the USA. Due to the 3-year citation 
Alternative quality indices
Having reported our main results, we now expand the discussion to the two variations of the ISR index. We briefly summarize results for patent quality according to the six technology areas electrical engineering, chemistry, mechanical engineering, consumer goods and construction, instruments, and process engineering. Patents in the field of electrical engineering, which constitute with 57% the majority of China's PCT applications, exhibit the largest difference between index F (27.5%) and index FDS (97.6%). The dominance of electrical engineering is related to the activities of ZTE and Huawei, two globally operating ICT firms that together file one third of Chinese PCT applications. Both firms receive fewer foreign citations than the average Chinese application but, as is consistent with their large size, exhibit considerably more self-citations. Applications in chemistry, the second largest category with 13%, display the smallest difference between index F (38.4%) and index FDS (49.3%). In contrast to the complex technology electrical engineering, chemistry is a discrete technology and is not dominated by a few firms. The differences in the remaining technology areas are in between those reported for electrical engineering and chemistry.
Validation of indices
The expansion of Chinese PCT applications may contribute to higher levels and annual increases of index FD and index FDS . This is the case regardless of actual patent quality, as it simply means that there are more citing applications. With China as the focal country, the effect on domestic citations requires further investigation, whereas the effect on citations received by the international comparison group is negligible -only 3.8% of foreign non-selfcitations originate from China. As China's patent expansion has been driven by economic We calculate the ISR indices for patent portfolios of all domestic firms listed in mainland China and regress the indices on relevant firm characteristics. Table 3 provides descriptive statistics for firms with at least one PCT application and Table 4 shows the regression results. For the analysis we use a Tobit model because the dependent variable is truncated at zero. Given that R&D is a leading input factor for patent quality, we expect that citations increase in the R&D stock of firms. While the significant relationship of index F with R&D confirms that foreign PCT applications more often cite patents from Chinese firms with more extensive R&D, this relationship cannot be confirmed for index FD and index FDS . The reliability of Chinese citations as a measure of quality must therefore be questioned. We conclude that index F is the most appropriate ISR index for measuring patent quality in the Chinese context. As economic policy has no direct influence on the index, changes in index F reflect true variation in patent quality. Additional robustness exercises can be found in the appendix.
Discussion
We derive two implications from our analysis. First, the expansion of Chinese PCT applications has occurred at the cost of patent quality. Although China has undergone an unforeseen increase in patent applications (Porter and Stern 1999) , its technological capacity has increased less than would be expected if one considers only the number of patents applied for. Quality-adjusted patent counts should therefore be used by policymakers and R&D managers when comparing national technological capacities. Second, we empirically confirm that measures stop serving as reliable measures if they become the target of economic policy (Goodhart 1975 , Lucas 1976 . In response to subsidies, for example, Chinese applicants divide inventions into several applications in order to increase subsidy income (Lei et al. n.d.) .
Accordingly, Chinese patent applications and citations thereof are questionable measures of innovation levels and quality.
Having achieved a vast expansion in the number of applications made both domestically and abroad, the Chinese government must now ensure that China's rising R&D investments, which are forecasted to overtake those of the USA in 2019 (OECD 2014), yield higher patent quality and thereby contribute to technological capacity and economic growth. 
A. 2. Determination of prior art for PCT applications
In the PCT system, applicants are encouraged to provide references to prior art. The description of the application should "indicate the background art which, as far as known to the applicant, can be regarded as useful for the understanding, searching and examination of the invention, and, preferably, cite the documents reflecting such art" (Rule 5 of WIPO 2014c). This PCT rule strikes a balance between the regulations of the US Patent and Trademark Office (USPTO) and the European Patent Office (EPO). Whereas the USPTO requires applicants to provide references to all relevant prior art that they are aware of, the EPO requires only that examiners, and not applicants, carry out this task (Michel and Bettels 2001 
A. 3. Potential language barriers in the selection of prior art
Potential language barriers deter patent examiners from identifying prior art from a specific country and must therefore be accounted for in international comparisons of patent quality.
Patent examiners typically begin their search for prior art with a keyword search in English, "The abstract shall be so drafted that it can efficiently serve as a scanning tool for purposes of searching in the particular art, especially by assisting the scientist, engineer or researcher in formulating an opinion on whether there is a need for consulting the international application itself". PCT applications, even if not originally published in English, are therefore easily identifiable as potentially relevant prior art.
According to further guidelines of the PCT system, patent examiners conducting the international search must have access to the minimum documentation, which specifies the set of prior art that examiners must be able to search. PCT applications, irrespective of the publication language, belong to the minimum documentation and are therefore fully accessible during the search process. Patent applications belonging to the minimum documentation are typically included in the databases most commonly used for search by examiners (e.g. Derwent World Patents Index (DWPI), Chemical Abstracts Service (CAS), and EPOQUE at the EPO).
When it comes to deciding whether a document is ultimately to be included as prior We quantify the language bias by calculating the share of non-self-citations from outside of China in all non-self-citations made before and after an English equivalent is available.
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As this share increases by 38 percentage points, from 31% to 69%, we arrive at an adjustment factor of 1.38 for the set of PCTs that do not obtain an English equivalent during the full 3-year citation window (1,095 days). For PCTs that obtain an English equivalent within three years, we weight the adjustment factor by 664/1,095 to account for the average time period after which an English equivalent is obtained, namely 664 days after publication.
PCTs with English equivalents at publication are not subject to bias and require no correction.
Taking the relative importance of the three groups into account, our weighted correction factor for ISR index F is 1.11.
3
As the increase of foreign citations is partially a result of the time required for the geographic diffusion of knowledge (Jaffe et al. 1993 , Peri 2005 , the calculated correction factor represents an upper limit for the pure language bias.
2 Self-citations from outside China may occur if an international subsidiary of a Chinese firm cites inventions of its mother company.
3 The size of the language barrier is substantial for affected applications but the overall effect is smaller as not all applications are affected to the full extend. A more detailed analysis of the role of language barriers for the content of search reports requires future research.
A. 4. Impact of China's patent policies
China's patent expansion follows quantitative targets set by governmental economic policies. Research not only indicates a positive influence of patent subsidies on patent expansion (Li 2012) , but also shows that in response to subsidies, applicants divide inventions into several applications in order to increase subsidy income (Lei et al. n.d.) . Interestingly, these studies do not find a decrease in the grant rate. Consequently, it seems that China's economic policy not only increases the number of patent applications made, but also lowers examination standards, therefore making grant rates an unreliable measure of patent quality.
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SIPO itself voiced its dissatisfaction in regard to this development. It has recently published two documents that criticize the abundance of provincial and city-level subsidies for patent applications and the low examination standards at provincial and city-level patent offices (State Intellectual Property Office 2013 , 2014 . SIPO suggests that increases in the number of applications are detrimental to average patent quality and demands stricter monitoring of examination standards. Furthermore, SIPO proposes that application-based subsidy schemes are replaced by schemes based on actual grants, thereby reducing excessive applications and favoring patent quality over quantity.
B. External validation of ISR indices -Additional analysis for listed firms
B. 1. Data
In order to externally validate our ISR indices we calculate them for the applications of Provincial GDP per capita is obtained from the Chinese National Bureau of Statistics.
B. 2. Regression analysis B. 2.1 Dependent variables
We use regression analysis for the external validation of the ISR indices. The dependent variables include index F , index FD , index FDS and, in addition, two indices that exclusively consider domestic or self-citations. As a first step, we compare the patent quality in the sample of listed firms (Table B1 ) with the quality of all Chinese PCT applications (Table 1) .
Whilst the values for index F and index FD are very similar, we see a larger value for index FDS . This is to be expected as listed firms are larger than average firms. We then move from the patent level to the firm-year level and calculate the average index value over all PCT applications filed by a firm in a given year for each observation. The statistics for our main indices are provided in Table B2 . Index F has an average value of 43.3%, index FD of 76.4%, and index FDS of 87.5%. The averages in Table B2 differ from those in Table B1 due to weighting. At the patent level, each patent has the same weighting, whereas at firm-year level each firm observation has the same weighting regardless of the size of the patent stock.
B. 2.2 Firm characteristics and standard controls
We briefly discuss the descriptive statistics of the firm characteristics for the 228 firms with PCT applications for which we have 451 observations (Table B2) . Employing the perpetual investment method, we calculate deflated R&D stocks based on an assumed annual growth rate of R&D of 20% and a standard annual depreciation rate of 15%. The resulting median R&D stock has a value of 30.45 million RMB. PCT and domestic patent intensity are calculated as the respective patent stocks of the firm depreciated by an annual rate of 15% and scaled by '000 employees. We find that intensity is much smaller for PCT than for domestic applications. Firms with PCT applications are relatively large; the median number of employees is 3,126 and the firms themselves tend to be relatively young, with a median age of 11 years. We broadly differentiate between firms with and without any government ownership and find, that according to this differentiation, 41.7% of observations are private firms. To allow for differences in China's economic development, we control for deflated GDP per capita at the provincial level. In addition, we account for macro-economic shocks and industry-specific effects by including year-and industry-dummies, respectively.
B. 2.3 Results
In Table B3 we estimate a Tobit model with standard errors clustered at the firm-level. For the analysis we use a Tobit model because the dependent variable is truncated at zero. Average marginal effects are listed to the right of coefficients. In Model (1) we regress index F on our set of firm characteristics and standard controls. We find positive and highly significant effects (p<0.01) for the R&D stock and PCT intensity, but a significantly negative effect Given that the expected correlation between R&D stock and patent quality is confirmed only for index F , we aim to estimate the effect of the R&D stock on two indices that exclusively consider either domestic or self-citations in Model (4) and (5). These models fail to show a significant relation between R&D stock and patent quality. Whilst we fail to identify any significant effects in Model (4), Model (5) reveals a positive and highly significant (p<0.01) correlation of ISR self-citations with PCT intensity and firm size (measured by the number of employees). In addition, the domestic patent intensity has a negative and highly significant (p<0.01) effect. Model (5) resembles the findings of Model (3) with higher significance levels and larger marginal effects. In addition, Model (5) To summarize, these findings suggest that index F is the preferable measure of patent quality in China because domestic citations and self-citations are not correlated with R&D stocks. We therefore perform additional robustness tests for index F , which are reported in Table B4 . For ease of reference we repeat the standard Tobit results as Model (1). In Model In Models (3a) and (3b) we not only consider firms with PCT applications but include all listed firms. We estimate the selection and outcome equation of a Heckman two-step selection model using the number of employees as an exclusion restriction. Our results show that large firms are more likely to file PCTs. Indeed, the number of employees has a nontrivial and positive effect at the 1% significance level on selection. As expected, confirms a positive correlation of residuals in the selection and outcome equation. Nonetheless, the coefficient of , which is the covariance of the error terms of both equations, is not significant. This finding shows that additional unobservables are unlikely to induce significant selection bias. We find that the R&D stock has a positive and highly significant effect (p<0.01) on the probability of filing at least one PCT application (Model 3a) and a positive and highly significant effect (p<0.01) on receiving foreign ISR citations (Model 3b). The marginal effect of the R&D stock in Model (3b) is smaller than in Model (1), as the first stage in Model (3a) already partly captures its influence on PCT applications. Note: Analysis at firm-year level. The dependent variable is the average index F of a firm's annual patent applications (models 1, 2 and 4). The dependent variable of the first stage of the Heckman two-step selection model is a dummy indicating whether the firm has at least one PCT application (model 3). The RE Tobit model includes the Chamberlain-Mundlak device. Average marginal effects are reported in square brackets. ***, **, * indicate statistical significance at the 1%, 5%, and 10% levels.
C) Additional analysis for PCT applications
In Table C1 we report citation counts for Chinese and non-Chinese PCT applications.
Between 2001 and 2009, the decline of index F , from 44.9% to 30.4% (as reported in Table 2 of the main paper), is a result of the decrease in the average number of citations obtained by
Chinese PCT applications in comparison to the relatively stable number obtained by the comparison group. Similarly, the increases of index FD and index FDS are due to increases in the average number of citations obtained by Chinese PCT applications, whereas the citations obtained by the non-Chinese comparison group are also stable over time.
In order to consider the quality development of Chinese PCT applications from an international perspective, we calculate the average citation count according to the definition of index F for the 19 largest applicant countries, including China. Table C2 provides To provide more general insight, we also present average citation counts according to the actual technology composition of each country. This corresponds to a country's general development, independent from the comparison with China (Table C3 ). China again has the smallest average citation count. In this representation, however, the count is decreasing in ten countries (US, JP, DE, FR, GB, CN, CH, IT, IL, BE), constant in eight countries (KR, NL, SE, CA, FI, ES, DK, AT), and increasing in one country (AU). 
